SOCS3 and neoplasm: These findings may have strong implications for restoring anti-tumor immunity in vivo and are supported by the report that the deletion of SOCS3 in 786-O xenografts can enhance the growth-inhibitory effect of IFN-alpha in vitro and in vivo (44).